Understanding the financial aspects of healthcare, especially for crucial tests like hereditary cancer screenings, is paramount. Quest Diagnostics is committed to making these vital tests accessible. Recognizing that cost can be a concern, they offer various financial assistance programs to ensure that patients who need hereditary cancer testing can afford it. This commitment includes several options designed to alleviate financial strain and facilitate necessary testing.
Exploring Financial Assistance Programs at Quest Diagnostics
Quest Diagnostics provides a comprehensive financial assistance program designed to significantly reduce out-of-pocket expenses for eligible patients. For individuals and families meeting specific income criteria, the program offers a capped expense of just $200 for a range of qualified hereditary cancer tests. This initiative aims to remove financial barriers, ensuring that cost-sensitive patients can still access essential genetic testing.
Furthermore, for uninsured and underinsured patients facing even greater financial hardship, Quest Diagnostics extends its support even further. Those with incomes at or below the federal poverty level may be eligible to receive testing at no charge. This zero-cost option is a testament to Quest Diagnostics’ dedication to public health, ensuring that even the most financially vulnerable individuals can benefit from early cancer risk detection.
Beyond these programs, Quest Diagnostics also understands the need for flexible payment solutions. For patients requiring additional support in managing their healthcare expenses, they offer 0% financing payment plans spread over a 12-month period. While specific details about acceptance of particular credit services like Care Credit aren’t explicitly outlined in the program details, the availability of payment plans indicates a commitment to working with patients to find manageable ways to pay for testing. It is recommended to contact Quest Diagnostics directly to discuss all available payment options and determine the best solution for individual financial circumstances.
Hereditary Cancer Tests Covered Under Financial Assistance
The financial assistance programs at Quest Diagnostics are applicable to a wide array of hereditary cancer tests, ensuring broad coverage for patients needing various screenings. These tests include, but are not limited to:
- Comprehensive Hereditary Cancer Panel
- Guideline-Based Hereditary Cancer Panel
- Hereditary Breast Cancer Panel
- Hereditary Colorectal Cancer Panel
- Hereditary Endocrine Cancer Panel
- BRCA Panel Plus
- BRCA Panel (BRCA1, BRCA2)
- BRCA Ashkenazi Jewish Screen
- BRCA Ashkenazi Jewish Screen w/Reflex to BRCA Panel (BRCA1, BRCA2)
- BRCA1 and BRCA2 Deletion and Duplication
- Lynch Syndrome Panel
- Nevoid Basal Cell Carcinoma (NBCCS) (Gorlin) Syndrome Panel (PTCH1, SUFU)
- Tuberous Sclerosis Complex Panel (TSC1, TSC2)
- Juvenile Polyposis Panel (BMPR1A, SMAD4)
- Hereditary Cancer Single-site(s) test
- Hereditary Cancer Single-gene tests
This extensive list demonstrates Quest Diagnostics’ commitment to providing financial relief across a broad spectrum of crucial hereditary cancer screenings.
Contact Quest Diagnostics for Payment and Financial Aid Details
Navigating healthcare costs can be complex, and understanding your payment options is essential. To get precise information about payment methods, including inquiries about specific services like Care Credit, and to explore your eligibility for financial assistance, it’s best to directly contact Quest Diagnostics. Their dedicated support team can provide detailed insights into available programs, payment plan options, and answer any specific questions you may have regarding your financial situation and testing costs. You can reach Quest Diagnostics at 1.866.GENE.INFO (1.866.436.3463) to discuss your needs and discover how they can help make hereditary cancer testing accessible and affordable for you.
